COR (Cencora) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

COR Cencora Inc COR
80 GF Score
Price $308.78
GF Value $304.18
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Cencora Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cencora  (NYSE:COR) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Cencora Cyclically Adjusted PS Ratio Related Terms


Cencora Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Cencora's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cencora Cyclically Adjusted PS Ratio Chart

Cencora Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.16 0.18 0.21 0.26

Cencora Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.26 0.27 0.25 0.22

COR vs CAH, MCK, HSIC: Cyclically Adjusted PS Ratio Comparison

For the Medical Distribution subindustry, Cencora's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cencora Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cencora's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cencora's Cyclically Adjusted PS Ratio falls into.


COR
80GF Score
Cencora Inc COR
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cencora Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Cencora's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Cencora's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=437.007/333.9520*333.9520
=437.007

Current CPI (Jun. 2026) = 333.9520.

Cencora Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 165.572 241.428 229.025
201612 171.950 241.432 237.844
201703 167.920 243.801 230.012
201706 174.456 244.955 237.839
201709 179.038 246.819 242.243
201712 183.253 246.524 248.242
201803 184.585 249.554 247.011
201806 195.426 251.989 258.991
201809 199.075 252.439 263.357
201812 212.145 251.233 281.994
201903 203.797 254.202 267.734
201906 214.241 256.143 279.321
201909 217.655 256.759 283.092
201912 230.655 256.974 299.749
202003 229.002 258.115 296.285
202006 220.716 257.797 285.917
202009 241.285 260.280 309.580
202012 253.947 260.474 325.584
202103 237.099 264.877 298.930
202106 255.637 271.696 314.213
202109 279.457 274.310 340.218
202112 282.376 278.802 338.233
202203 272.273 287.504 316.260
202206 283.674 296.311 319.710
202209 291.360 296.808 327.822
202212 304.598 296.797 342.730
202303 310.675 301.836 343.731
202306 327.570 305.109 358.536
202309 338.860 307.789 367.664
202312 357.976 306.746 389.726
202403 340.070 312.332 363.610
202406 371.120 314.175 394.482
202409 399.078 315.301 422.685
202412 417.480 315.605 441.749
202503 386.755 319.799 403.871
202506 413.172 322.561 427.763
202509 431.815 324.800 443.982
202512 439.957 324.054 453.395
202603 401.038 330.213 405.579
202606 437.007 333.952 437.007

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Cencora (COR) Overvalued in 2026?

Based on GuruFocus' analysis, Cencora stock appears to be overvalued. The current stock price of $308.78 is trading 1.5% above its estimated GF Value™ of $304.18. GuruFocus considers Cencora to be Fairly Valued.

Key valuation signals for COR:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $304.18 vs. price of $308.78 (1.5% above fair value)
  • GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the COR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cencora Business Description

Address 1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
80GF Score

Get the complete analysis for COR

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$308.78
Price
$304.18
GF Value